Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 8, 2019
Patent Application Number
15268298
Date Filed
September 16, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
Therapeutic combinations of immunoconjugates that bind to FOLR1 (e.g., IMGN853) with anti-VEGF agents (e.g., bevacizumab), a platinum-based agent, and/or doxorubicin are provided. Methods of administering the combinations to treat cancers, e.g., ovarian cancers, with greater clinical efficacy and/or decreased toxicity are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
